Biotech Cyclacel Pharmaceuticals Reviews 2022 Achievements and Announces Key Business Objectives for 2023 January 5, 2023
Biotech CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch Event January 5, 2023
Biotech Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures January 5, 2023
Biotech Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate January 5, 2023
Biotech MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm January 5, 2023
Biotech Galectin Therapeutics Announces the End of Enrollment of NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Liver Cirrhosis Caused by Non-Alcoholic Steatohepatitis January 5, 2023
Biotech EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines January 5, 2023
Search
biotechnology
January 5, 2023
January 5, 2023
January 5, 2023
January 5, 2023
January 5, 2023
January 5, 2023
January 5, 2023
January 5, 2023
January 5, 2023
January 5, 2023
